Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7535 in heart failure with preserved ejection fraction and obesity
NCT06820099Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7535 in heart failure with preserved ejection fraction (HFpEF), sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Apr 2025; status: recruiting.
02
Drugs
HRS-7535
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT06820099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06820099.